Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A simple and improved method to generate human hybridomas.

T Kudo¹, H Saeki, T Tachibana

¹Cancer Cell Repository, Tohoku University, Sendai, Japan.

Journal of Immunological Methods

|December 15, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

T-cell invigoration to cell-free DNA ratio associated with anti-PD-1 response in gastric or gastro-esophageal junction adenocarcinoma: VOYAGER trial.

ESMO gastrointestinal oncology·2026

Same author

Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).

ESMO open·2021

Same author

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial.

The British journal of dermatology·2021

Same author

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.

The British journal of dermatology·2021

Same author

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.

The British journal of dermatology·2020

Same author

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

The British journal of dermatology·2020

This study presents an improved, efficient method for producing human hybridomas. The new technique enhances fusion frequency and reduces the time and number of human B cells required.

Area of Science:

Immunotechnology
Cell Biology
Hybridoma Technology

Background:

Human hybridoma production is crucial for monoclonal antibody development.
Previous methods faced challenges with efficiency and resource requirements.

Purpose of the Study:

To develop a simpler and more efficient method for human hybridoma production.
To improve fusion frequency and reduce the time and cell input needed.

Main Methods:

Incorporated irradiated myeloma cells as feeder cells.
Reduced ouabain concentration in selective medium.
Optimized the timing of selective medium (GIT-HAT-OL) addition.

Main Results:

Achieved a significantly higher fusion frequency (1/700) compared to the previous method (1/5500).

Related Experiment Videos

Demonstrated the ability to produce human hybridomas with a smaller number of human B cells (EBV-LCL).

Conclusions:

The refined method offers a more efficient and streamlined approach to human hybridoma generation.
This advancement reduces the time and resources necessary for establishing human hybridomas.